7bsa
From Proteopedia
(Difference between revisions)
(One intermediate revision not shown.) | |||
Line 3: | Line 3: | ||
<StructureSection load='7bsa' size='340' side='right'caption='[[7bsa]], [[Resolution|resolution]] 1.22Å' scene=''> | <StructureSection load='7bsa' size='340' side='right'caption='[[7bsa]], [[Resolution|resolution]] 1.22Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'> | + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7BSA OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7BSA FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=6SO:2-(5-chloranyl-1~{H}-indol-3-yl)ethanamine'>6SO</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.22Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=6SO:2-(5-chloranyl-1~{H}-indol-3-yl)ethanamine'>6SO</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> | |
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7bsa FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7bsa OCA], [https://pdbe.org/7bsa PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7bsa RCSB], [https://www.ebi.ac.uk/pdbsum/7bsa PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7bsa ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7bsa FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7bsa OCA], [https://pdbe.org/7bsa PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7bsa RCSB], [https://www.ebi.ac.uk/pdbsum/7bsa PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7bsa ProSAT]</span></td></tr> | ||
</table> | </table> | ||
- | <div style="background-color:#fffaf0;"> | ||
- | == Publication Abstract from PubMed == | ||
- | Room-temperature (RT) protein crystallography provides significant information to elucidate protein function under physiological conditions. In particular, contrary to typical binding assays, X-ray crystal structure analysis of a protein-ligand complex can determine the three-dimensional (3D) configuration of its binding site. This allows the development of effective drugs by structure-based and fragment-based (FBDD) drug design. However, RT crystallography and RT crystallography-based protein-ligand complex analyses require the preparation and measurement of numerous crystals to avoid the X-ray radiation damage. Thus, for the application of RT crystallography to protein-ligand complex analysis, the simultaneous preparation of protein-ligand complex crystals and sequential X-ray diffraction measurement remain challenging. Here, we report an RT crystallography technique using a microfluidic protein crystal array device for protein-ligand complex structure analysis. We demonstrate the microfluidic sorting of protein crystals into microwells without any complicated procedures and apparatus, whereby the sorted protein crystals are fixed into microwells and sequentially measured to collect X-ray diffraction data. This is followed by automatic data processing to calculate the 3D protein structure. The microfluidic device allows the high-throughput preparation of the protein-ligand complex solely by the replacement of the microchannel content with the required ligand solution. We determined eight trypsin-ligand complex structures for the proof of concept experiment and found differences in the ligand coordination of the corresponding RT and conventional cryogenic structures. This methodology can be applied to easily obtain more natural structures. Moreover, drug development by FBDD could be more effective using the proposed methodology. | ||
- | + | ==See Also== | |
- | + | *[[Trypsin 3D structures|Trypsin 3D structures]] | |
- | + | ||
- | + | ||
- | + | ||
- | == | + | |
- | + | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: Bos taurus]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | + | [[Category: Funakubo T]] | |
- | [[Category: Funakubo | + | [[Category: Ishida A]] |
- | [[Category: Ishida | + | [[Category: Ito S]] |
- | [[Category: Ito | + | [[Category: Maeki M]] |
- | [[Category: Maeki | + | [[Category: Takeda R]] |
- | [[Category: Takeda | + | [[Category: Tani H]] |
- | [[Category: Tani | + | [[Category: Tokeshi M]] |
- | [[Category: Tokeshi | + | [[Category: Ueno G]] |
- | [[Category: Ueno | + | [[Category: Yamamoto M]] |
- | [[Category: Yamamoto | + | |
- | + | ||
- | + | ||
- | + | ||
- | + |
Current revision
Bovine Pancreatic Trypsin with 5-Chlorotryptamine (Cryo)
|
Categories: Large Structures | Funakubo T | Ishida A | Ito S | Maeki M | Takeda R | Tani H | Tokeshi M | Ueno G | Yamamoto M